Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Low-coverage genome sequencing for the detection of clinically relevant copy-number and mtDNA variants

View ORCID ProfileSander Pajusalu, View ORCID ProfileMikk Tooming, Kaisa Teele Oja, Ustina Šamarina, Tiina Kahre, View ORCID ProfileKatrin Õunap
doi: https://doi.org/10.1101/2022.09.20.22280155
Sander Pajusalu
1Department of Clinical Genetics, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia
2Genetics and Personalized Medicine Clinic, Tartu University Hospital, Tartu, Estonia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sander Pajusalu
  • For correspondence: sander.pajusalu@ut.ee
Mikk Tooming
1Department of Clinical Genetics, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia
2Genetics and Personalized Medicine Clinic, Tartu University Hospital, Tartu, Estonia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mikk Tooming
Kaisa Teele Oja
1Department of Clinical Genetics, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia
2Genetics and Personalized Medicine Clinic, Tartu University Hospital, Tartu, Estonia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ustina Šamarina
2Genetics and Personalized Medicine Clinic, Tartu University Hospital, Tartu, Estonia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tiina Kahre
1Department of Clinical Genetics, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia
2Genetics and Personalized Medicine Clinic, Tartu University Hospital, Tartu, Estonia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katrin Õunap
1Department of Clinical Genetics, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia
2Genetics and Personalized Medicine Clinic, Tartu University Hospital, Tartu, Estonia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Katrin Õunap
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Compared to exome sequencing, genome sequencing is widely appreciated for its superior ability to detect a wide range of genetic variations including copy-number variants (CNVs) and mitochondrial (mtDNA) variants. We assessed whether low-coverage genome sequencing, a considerably cheaper approach, would detect clinically relevant CNVs and mtDNA variants and would thus be a cost-efficient supplement to exome sequencing in rare disease diagnostics.

Methods To assess the level of sequencing depth needed for variant detection, first, 30x mean coverage genome sequencing data were subsampled to 0.5x, 1x, 2x, and 4x coverage files in silico followed by CNV and mtDNA detection. Based on the analysis, 2x short-read sequencing was selected to be performed in 16 patients with putatively pathogenic CNVs or mtDNA variants to assess the empirical sensitivity.

Results For CNV calling, 2x coverage was sufficient to detect all heterozygous CNVs greater than 10kb in size from in silico subsampled data. In experimental data, the results were similar, although a 16kb heterozygous deletion was once not detected. Regarding mtDNA variants, 2x coverage sufficed for variant confident variant calling and heteroplasmy assessment for all samples.

Conclusions Low-coverage genome sequencing may be used to complement exome sequencing for simultaneous mtDNA variant and CNV detection.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was supported by European Regional Development Fund and the program Mobilitas Pluss grant MOBTP175. KO, TK, KTO, and MT received support from the Estonian Research Council grants PRG471 and PUT355. The high coverage genome sequencing used for methods development was provided by the Broad Institute of MIT and Harvard Center for Mendelian Genomics (Broad CMG) and was funded by the National Human Genome Research Institute, the National Eye Institute, and the National Heart, Lung and Blood Institute grant UM1 HG008900 and in part by National Human Genome Research Institute grant R01 HG009141.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Research Ethics Committee of the University of Tartu gave ethical approval for this work (approval date 11/18/2018 and number 287M-15, and 19/10/2020 327T-3).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Grant numbers MOBTP175, PRG471, PUT355, UM1 HG008900, R01 HG009141

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted September 23, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Low-coverage genome sequencing for the detection of clinically relevant copy-number and mtDNA variants
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Low-coverage genome sequencing for the detection of clinically relevant copy-number and mtDNA variants
Sander Pajusalu, Mikk Tooming, Kaisa Teele Oja, Ustina Šamarina, Tiina Kahre, Katrin Õunap
medRxiv 2022.09.20.22280155; doi: https://doi.org/10.1101/2022.09.20.22280155
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Low-coverage genome sequencing for the detection of clinically relevant copy-number and mtDNA variants
Sander Pajusalu, Mikk Tooming, Kaisa Teele Oja, Ustina Šamarina, Tiina Kahre, Katrin Õunap
medRxiv 2022.09.20.22280155; doi: https://doi.org/10.1101/2022.09.20.22280155

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1096)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9772)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2312)
  • Geriatric Medicine (223)
  • Health Economics (462)
  • Health Informatics (1561)
  • Health Policy (736)
  • Health Systems and Quality Improvement (603)
  • Hematology (238)
  • HIV/AIDS (504)
  • Infectious Diseases (except HIV/AIDS) (11649)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (238)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2144)
  • Nursing (134)
  • Nutrition (337)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1179)
  • Ophthalmology (364)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (146)
  • Palliative Medicine (50)
  • Pathology (311)
  • Pediatrics (695)
  • Pharmacology and Therapeutics (300)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2182)
  • Public and Global Health (4661)
  • Radiology and Imaging (778)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)